1 | 13NH3 PET/CT scan | - | - | - | - | [1] 84 84 |
2 | 18F-DOPA PET | - | - | - | - | [1] 6 6 |
3 | 18FDG PET/CT scan | - | - | - | - | [1] 84 84 |
4 | 68Ga-DOTA-TATE PET/MR and PET/CT imaging | [1] Dotatate Dotatate | - | - | - | [1] 238 238 |
5 | 68Ga-DOTATATE PET/CT | [2] Dotatate Dotatate, Dotatate gallium Ga-68 | - | - | - | [1] 84 84 |
6 | [18F] LBT-999 PET | - | - | - | - | [1] 6 6 |
7 | [18F]-FLT-PET/CT scans | - | - | - | - | [1] 34 34 |
8 | [18F]DPA-714 PET | - | - | - | - | [1] 2 2 |
9 | [18F]DPA-714 PET scan | - | - | - | - | [1] 6 6 |
10 | [18F]FDOPA PET/CT | - | - | - | - | [1] 6 6 |
11 | [18F]Florbetapir PET imaging | - | - | - | - | [1] 13 13 |
12 | [18F]FPEB PET imaging | - | - | - | - | [1] 206 206 |
13 | [C11]PK-1195 PET scan | - | - | - | - | [1] 13 13 |
14 | [Zr-89]Oxine-labeled leukocytes PET/MR | [1] Oxyquinoline Oxyquinoline | [1] D05321
D05321
| - | - | [1] 13 13 |
15 | Brain PET scan | - | - | - | - | [3] 5 5, 7, 127 |
16 | Cellulose acetate with petrolatum | [3] Acetate Acetate, Microcrystalline cellulose, Petrolatum | [2] D00093
D00093
,
D05331
(Name: Petrolatum) | - | - | [2] 35 35, 162 |
17 | Combination Product: 68Ga-DOTATATE PET/CT | [2] Dotatate Dotatate, Dotatate gallium Ga-68 | - | - | - | [1] 238 238 |
18 | Cotton gauze with petrolatum | [2] Cotton Cotton, Petrolatum | [1] D05331
D05331
(Name: Petrolatum) | - | - | [2] 35 35, 162 |
19 | Diagnostic Test: 11C-UCB-J PET-CT | - | - | - | - | [1] 8 8 |
20 | Diagnostic Test: 18F-FDG and 68Ga-FAPI PET/CT | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 96 96 |
21 | Diagnostic Test: 18F-FDG PET-MR | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 8 8 |
22 | Diagnostic Test: 18F-FDG-PET/MRI | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 84 84 |
23 | Diagnostic Test: 18F-GE180-PET/MRI | - | - | - | - | [1] 84 84 |
24 | Diagnostic Test: 68-Ga HA-DOTATATE PET/CT | [1] Dotatate Dotatate | - | - | - | [1] 41 41 |
25 | Diagnostic Test: 68Ga-DOTA-TOC PET/CT | - | - | - | - | [1] 84 84 |
26 | Diagnostic Test: Entire-body PET-CT scans | - | - | - | - | [1] 13 13 |
27 | Diagnostic Test: FDG-PET/CT with Rb82 Myocardial Perfusion Imaging | - | - | - | - | [1] 84 84 |
28 | Diagnostic Test: PET Imaging | - | - | - | - | [1] 85 85 |
29 | Diagnostic Test: PET with [11C]Flumazenil | [1] Flumazenil Flumazenil | [1] D00697
D00697
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 13 13 |
30 | Diagnostic Test: PET-CT Imaging with [89Zr]-bevacizumab | [1] Bevacizumab Bevacizumab | [1] D06409
D06409
| [1] VEGFA VEGFA 💬 | [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1] 86 86 |
31 | Diagnostic Test: simultaneous combined 18F-FDG PET and cardiac MRI imaging | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 84 84 |
32 | DPA-714 PET/MRI | - | - | - | - | [1] 13 13 |
33 | DPA-714-PET/MRI | - | - | - | - | [1] 6 6 |
34 | ESR-specific PET scan | - | - | - | - | [1] 86 86 |
35 | FDG-PET | - | - | - | - | [1] 299 299 |
36 | GE180 PET Scan | - | - | - | - | [1] 6 6 |
37 | Morphine, buprenorphine, pethidine, tramaldol, metamizole and acetylsalicylacid (Analgesics) | [4] Buprenorphine Buprenorphine, Meperidine (Synonym: Pethidin), Metamizole, Morphine | [8] D00836
D00836
,
D00842
,
D01383
(Name: Pethidine hydrochloride (JP18)),
D02271
,
D07132
,
D08188
,
D08233
,
D08343
(Name: Pethidine) | [2] OPRK1 OPRK1, OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 298 298 |
38 | MRI, FDG-PET/CT scans | - | - | - | - | [1] 34 34 |
39 | Other: 18F-FDG PET/CT | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 41 41 |
40 | Other: 18F-Fluorodeoxyglucose (18F-FDG) PET/CT | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 84 84 |
41 | Other: [11C]-Methionine PET/MRI | [1] Methionine Methionine | [2] D00019
D00019
,
D04983
| - | - | [1] 75 75 |
42 | Other: [11C]donepezil PET | [1] Donepezil Donepezil | [2] D00670
D00670
,
D07869
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 6 6 |
43 | PET | - | - | - | - | [1] 6 6 |
44 | PET with 11C-Flumazenil | [1] Flumazenil Flumazenil | [1] D00697
D00697
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 13 13 |
45 | PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714 | - | - | - | - | [1] 13 13 |
46 | PET/CT | - | - | - | - | [1] 6 6 |
47 | PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714 | - | - | - | - | [1] 85 85 |
48 | PET10 | - | - | - | - | [1] 41 41 |
49 | PET3 | - | - | - | - | [1] 41 41 |
50 | Pethidine | [1] Meperidine Meperidine (Synonym: Pethidin) | [2] D01383
D01383
(Name: Pethidine hydrochloride (JP18)),
D08343
(Name: Pethidine) | [1] OPRM1 OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 298 298 |
51 | Petrolatum | [1] Petrolatum Petrolatum | [1] D05331
D05331
(Name: Petrolatum) | - | - | [3] 35 35, 158, 162 |
52 | Radiation: 11C-MET PET/CT Imaging | - | - | - | - | [1] 53 53 |
53 | Radiation: 18F-FDG PET/CT Imaging | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 53 53 |
54 | Radiation: [18-Fluorine] Flubatine PET Scan | - | - | - | - | [1] 6 6 |
55 | Radiation: Cardiac PET imaging using F-18-FDG, N-13 ammonia( NH3) | [1] Ammonia Ammonia | [1] D02916
D02916
| - | - | [1] 88 88 |
56 | Radiation: DOTATATE PET-CT | [1] Dotatate Dotatate | - | - | - | [1] 75 75 |
57 | Radiation: F-DOPA PET CT | - | - | - | - | [1] 75 75 |
58 | Radiation: FDG PET scan | - | - | - | - | [1] 85 85 |
59 | Radiation: H215O PET | - | - | - | - | [2] 6 6, 17 |
60 | Radiation: PET (Positron Emission Tomography) Study | - | - | - | - | [1] 17 17 |
61 | Radiation: PET with the tracer 11C-PE2I | - | - | - | - | [1] 6 6 |
62 | Radiation: PET with the tracer 18F-DPA-714 | - | - | - | - | [1] 6 6 |
63 | Radiation: PET/CT Scan | - | - | - | - | [1] 67 67 |
64 | Radiation: PET/CT Scan: Two PET scans using 1. C-11 HED and 2. N-13 Ammonia or rubidium-82 | [2] Ammonia Ammonia, Rubidium | [1] D02916
D02916
| - | - | [1] 86 86 |
65 | Radiation: PET/MR with [11C]PBR28 | - | - | - | - | [1] 6 6 |
66 | Radiation: Rubidium PET | [1] Rubidium Rubidium | - | - | - | [1] 84 84 |
67 | Radiation: Stress myocardial perfusion PET | - | - | - | - | [1] 46 46 |